HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sherin Saheera Selected Research

Inflammation (Inflammations)

1/2020Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sherin Saheera Research Topics

Disease

3Hypertrophy
01/2022 - 12/2018
3Hypertension (High Blood Pressure)
01/2022 - 12/2018
3Cardiomegaly (Heart Hypertrophy)
01/2022 - 04/2019
3Heart Diseases (Heart Disease)
12/2018 - 01/2017
1COVID-19
03/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Pathologic Processes
01/2021
1Inflammation (Inflammations)
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Heart Failure
04/2019
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2018
1Ulcer
01/2017

Drug/Important Bio-Agent (IBA)

3Histamine (Histamine Dihydrochloride)FDA Link
01/2022 - 12/2018
2tempolIBA
01/2022 - 04/2019
2AntioxidantsIBA
01/2022 - 04/2019
2Metoprolol (Toprol-XL)FDA LinkGeneric
12/2018 - 04/2018
2Famotidine (Pepcid)FDA LinkGeneric
12/2018 - 01/2017
1Biomarkers (Surrogate Marker)IBA
03/2023
1Protein Isoforms (Isoforms)IBA
01/2022
1Oxidants (Oxidizing Agents)IBA
01/2022
1Histamine Antagonists (Antihistamines)IBA
01/2022
1Histamine Receptors (Histamine Receptor)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2021
1Lipid Bilayers (Lipid Bilayer)IBA
01/2021
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2021
1Angiotensin IIIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1AntigensIBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2018
1Hydroxyproline (4 Hydroxyproline)IBA
12/2018
1amthamineIBA
12/2018
1CollagenIBA
12/2018

Therapy/Procedure

1Therapeutics
01/2022